PRESS RELEASE: RE-LAUNCH OF “BOYCOTT NOVARTIS” CAMPAIGN

Novartis’ Supreme Court case threatens access to medicines in India and across the world

Drug Action Forum – Karnataka objects to Novartis’ long legal attack on health safeguards in India’s patent law

The Drug Action Forum – Karnataka (DAF-K), an organisation engaged in promoting issues related to public health in India, announces a call to boycott all products manufactured by Swiss MNC, Novartis, till Novartis withdraws its Supreme Court case (SC 20539 – 20549/2009) for seeking a patent on Glivec/Gleevec and abandon all its attempts and plans to misuse Indian decision making and redressal systems for its narrow ends. This is a renewal of the boycott call as the Supreme Court case hearing starts on 28^thMarch 2012. The hearing on 28^th March 2012 has posted the next hearing on Tuesday, 10^th July 2012, as a result of the Mumbai terror attack trial running months behind schedule. The division bench in the Supreme Court comprises of Justice Aftab Alam and Justice Ranjana P Desai  

THE FULL TEXT OF THE LETTER CAN BE DOWNLOADED FROM THE LINK GIVEN BELOW.  (express solidarity with the campaign by disseminating the DAF-K press release to local media)

http://www.mediafire.com/?r7fq0jasvpwibv1